Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 34.53K / 2.07M |
Day Range | - - - |
52 Wk Range | 0.14 - 5.00 |
Market Cap | $10.41M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 39 |
Short Interest | 2.14% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).
There is no analysis for Calidi Biotherapeutics.
Calidi Biotherapeutics has a consensus price target of $1.67.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $0.16515 last updated Today at July 9, 2024 at 9:02 AM EDT.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q2 earnings are confirmed for Sunday, August 18, 2024.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.